[Federal Register Volume 63, Number 176 (Friday, September 11, 1998)]
[Notices]
[Pages 48737-48738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-24370]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institutes of Health Clinical Center (NIHCC):
Opportunity for Cooperative Research and Development Agreement (CRADA)
in the Fields of Magnetic Resonance Imaging, Magnetic Resonance
Spectroscopy, Molecular Imaging, Image Processing, and Surgery Under
Image Guidance
AGENCY: Radiology Department, NIHCC, NIH, DHHS.
ACTION: Notice of CRADA Opportunity.
-----------------------------------------------------------------------
SUMMARY: The Radiology Department of the National Institutes of Health
Clinical Center (NIHCC), seeks Cooperative Research and Development
Agreements (CRADAs) with one or more medical equipment manufacturers to
collaborate on research projects designed to develop improved
technologies for radiological diagnosis and treatment. The term of the
CRADA will be up to four (4) years.
DATES: Interested parties should submit a brief statement indicating:
(i) area(s) of proposed research collaboration and (ii) interest in
submitting a formal proposal. Statements of interest should be
submitted to NIHCC in writing no later than December 10, 1998. Parties
will then have an additional thirty (30) days in which to submit a
formal proposal.
ADDRESSES: Inquiries and proposals regarding this opportunity should be
addressed to Steve Galen, Technology Development Coordinator, National
Institutes of Health, Warren Grant Magnuson Clinical Center, 6011
Executive Boulevard, suite 559B, Rockville, MD 20852. Phone: (301) 594-
4509, FAX (301) 402-2143.
SUPPLEMENTARY INFORMATION: A CRADA is the anticipated joint agreement
to be entered into by NIHCC pursuant to the Federal Technology Transfer
Act of 1986 as amended by the National Technology Transfer Act (Pub.L.
104-113 (Mar. 7, 1996)) and by Executive Order 12591 of April 10, 1987.
The CRADA objective is the rapid publication of research findings
and the timely commercialization of improved diagnostic and treatment
strategies in
[[Page 48738]]
the fields of Magnetic Resonance Imaging, Magnetic Resonance
Spectroscopy, Molecular Imaging, Image Processing, and Surgery Under
Image Guidance. Particular emphasis is placed on discoveries that
enhance clinical research.
Under a CRADA, the NIHCC can offer selected collaborators access to
facilities, staff, materials, and expertise. The collaborator may
contribute facilities, staff, materials, expertise and funding to the
collaboration. The NIHCC cannot contribute funding. The CRADA
collaborator may elect an option to an exclusive or non-exclusive
license to Government intellectual property rights arising under the
CRADA and may qualify as a co-inventor of new technology developed
under the CRADA.
CRADA proposals will be evaluated under the following criteria:
Corporate research and development competencies.
Demonstrated abilities to productively collaborate in
research programs.
The nature of resources to be contributed to the
collaboration.
Key staff expertise, qualifications and relevant
experience.
Willingness to assign technical staff to on-site
collaborative efforts.
Ability to effectively commercialize new discoveries.
Dated: August 26, 1998.
Kathleen Sybert,
Acting Director, Technology Development and Commercialization Branch,
National Institutes of Health.
[FR Doc. 98-24370 Filed 9-10-98; 8:45 am]
BILLING CODE 4140-01-M
